Ivan Bambir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ivan Bambir has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Vukić Dugac
Clinic for Respiratory Diseases, University Hospital Centre Zagreb, 10000 Zagreb, Croatia
2 shared publications - Duška Tješić-Drinković
Cystic Fibrosis Centre for Paediatrics and Adults, University Hospital Centre Zagreb, 10000 Zagreb, Croatia
2 shared publications - Amel Alameeri
Department of adult Pulmonary medicine, ST Shaikh Tahnoon medical City Hospital, Alain, AbuDhabi, UAE
1 shared publication Andrea Vukić Dugac
AEROSOL; INHALATOR INHALACIJSKA TERAPIJA TLAČNI DOZNI INHALER INHALER SUHOG PRAŠKA
1 shared publication- Burcu Capraz Yavuz
Department of Pediatric Pulmonology Faculty of Medicine, Hacettepe University Ankara Türkiye
1 shared publication Dalibor Šarić
AEROSOL; INHALATOR INHALACIJSKA TERAPIJA TLAČNI DOZNI INHALER INHALER SUHOG PRAŠKA
1 shared publication
Latest Publications
- Open Access
Prevalence and Characteristics of Patients with Cystic Fibrosis-Related Diabetes in Croatia
This study investigated the prevalence of cystic fibrosis-related diabetes (CFRD) in the Croatian cystic fibrosis (CF) population, the age at diagnosis, insulin requirements, and the relationship between age at diagnosis and other clinical parameters. Medical records from 152 patients with genetically and laboratory-confirmed CF were reviewed through to 2025. The American Diabetes Association criteria were used to diagnose CFRD. Anthropometric and clinical data were collected from the latest medical records. A total of 17 out of 152 patients had CFRD, with a prevalence of 4.8% in the paediatric population (4/84) and 19.1% in adults (13/68). The median age of CFRD diagnosis was 14 years (range 9–22 years, SD = 3.95). Thirteen patients used insulin: one used bolus only, seven used basal-bolus multiple daily injections, and five used insulin pumps. The average total daily insulin (TDI) per kilogram (kg) body weight was 0.447 U/kg (SD = 0.429). The age at CFRD diagnosis was positively correlated with the body mass index (BMI) (p = 0.029). Patients requiring insulin by age 15 had higher TDI and were more likely to have CF liver disease (p = 0.027, p = 0.037, respectively). The prevalence of CFRD and age at diagnosis aligned with previous studies. Patients diagnosed at a younger age and requiring insulin earlier had lower BMIs, likely due to a faster decline in beta cell function and earlier onset of insulinopenia.
Open AccessPrevalence and Characteristics of Patients with Cystic Fibrosis-Related Diabetes in Croatia
This study investigated the prevalence of cystic fibrosis-related diabetes (CFRD) in the Croatian cystic fibrosis (CF) population, the age at diagnosis, insulin requirements, and the relationship between age at diagnosis and other clinical parameters. Medical records from 152 patients with genetically and laboratory-confirmed CF were reviewed through to 2025. The American Diabetes Association criteria were used to diagnose CFRD. Anthropometric and clinical data were collected from the latest medical records. A total of 17 out of 152 patients had CFRD, with a prevalence of 4.8% in the paediatric population (4/84) and 19.1% in adults (13/68). The median age of CFRD diagnosis was 14 years (range 9–22 years, SD = 3.95). Thirteen patients used insulin: one used bolus only, seven used basal-bolus multiple daily injections, and five used insulin pumps. The average total daily insulin (TDI) per kilogram (kg) body weight was 0.447 U/kg (SD = 0.429). The age at CFRD diagnosis was positively correlated with the body mass index (BMI) (p = 0.029). Patients requiring insulin by age 15 had higher TDI and were more likely to have CF liver disease (p = 0.027, p = 0.037, respectively). The prevalence of CFRD and age at diagnosis aligned with previous studies. Patients diagnosed at a younger age and requiring insulin earlier had lower BMIs, likely due to a faster decline in beta cell function and earlier onset of insulinopenia.
- 18 February 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (2) , 218-223
Cystic fibrosis year in review 2024
- 18 February 2025
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 24 (2) , 218-223
Cystic fibrosis year in review 2024
- Open Access
- 17 April 2023
- Published by Croatian Medical Association in Lijecnicki Vjesnik
- Vol. 145 (Supp 1) , 123-127
Inhalacijska terapija u djece
Inhalacijska terapija jedan je od stupova liječenja plućnih bolesti. Na dostavu lijeka u pluća utječu anatomija dišnog sustava, fizikalno-kemijska svojstva samog lijeka te čimbenici prijenosa lijeka (sredstva za dostavljanje lijeka, tehnika disanja i...
- 17 April 2023
- Published by Croatian Medical Association in Lijecnicki Vjesnik
- Vol. 145 (Supp 1) , 123-127
Open AccessInhalacijska terapija u djece
Inhalacijska terapija jedan je od stupova liječenja plućnih bolesti. Na dostavu lijeka u pluća utječu anatomija dišnog sustava, fizikalno-kemijska svojstva samog lijeka te čimbenici prijenosa lijeka (sredstva za dostavljanje lijeka, tehnika disanja i...
- Open Access
- 25 April 2022
- Published by Croatian Medical Association in Lijecnicki Vjesnik
- Vol. 144 (Supp 1) , 27-35
Cystic fibrosis – new therapeutic aproaches
Uvod: Mongenska autosomno recesivno nasljedna bolest cistična fibroza (CF) prije pedesetak je godina završavala smrću u ranom djetinjstvu. Devedesetih se godina, zahvaljujući simptomatskom liječenju uz strukturiran, sveobuhvatan multidisciplinarni pr...
- 25 April 2022
- Published by Croatian Medical Association in Lijecnicki Vjesnik
- Vol. 144 (Supp 1) , 27-35
Open AccessCystic fibrosis – new therapeutic aproaches
Uvod: Mongenska autosomno recesivno nasljedna bolest cistična fibroza (CF) prije pedesetak je godina završavala smrću u ranom djetinjstvu. Devedesetih se godina, zahvaljujući simptomatskom liječenju uz strukturiran, sveobuhvatan multidisciplinarni pr...